Tenax Therapeutics
TENX
34 hedge funds and large institutions have $35.9M invested in Tenax Therapeutics in 2025 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 3 closing their positions.
350% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 2
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
178% more capital invested
Capital invested by funds: $12.9M → $35.9M (+$23M)
49.67% more ownership
Funds ownership: 53.8% → 103.47% (+50%)
31% more funds holding
Funds holding: 26 → 34 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$5.91M |
| 2 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$2.15M |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$2.15M |
| 4 |
VA
VR Adviser
New York
|
+$2.07M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$624K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$93K |
| 3 |
Raymond James Financial
St Petersburg,
Florida
|
-$8.66K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.57K |
| 5 |
Barclays
London,
United Kingdom
|
-$63 |
TENX Hedge Fund Activity: Q3 2025 in Review
34 of the 7,626 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q3 2025, worth a combined $35.9M — up 178% from $12.9M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new TENX positions and 3 closed out — a net gain of 8 holders — while 9 added to existing stakes and 2 trimmed.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $5.91M. The largest seller was ADAR1 Capital Management, cutting an estimated $624K.
- 34 institutional investors held Tenax Therapeutics (TENX) as of Q3 2025, up from 26 in Q2 2025.
- Funds reported $35.9M of Tenax Therapeutics stock for Q3 2025, up 178% quarter-over-quarter.
- 11 funds opened new Tenax Therapeutics positions in Q3 2025 and 3 closed out, a net change of +8 holders.
- The largest Tenax Therapeutics buyer in Q3 2025 was Ikarian Capital, an estimated $5.91M added.
- The largest Tenax Therapeutics seller in Q3 2025 was ADAR1 Capital Management, an estimated $624K sold.
Based on aggregated 13F filings for Q3 2025.